
Withings, Babyscripts Team Up to Tackle Hypertensive Disorders of Pregnancy
Through a new partnership, Babyscripts members now have access to Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor.
Through a new partnership, Babyscripts members now have access to Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor.
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Withings announced that it is developing a miniaturized platform that can analyze urine at home. The device, called U-Scan, sits within a toilet bowl and assesses specific biomarkers found in urine.
Through the new partnership, Redox — which connects EHRs to healthcare products and services — will make Withings' remote patient monitoring solution compatible with nearly all EHRs used by physicians and hospitals.
After Withings co-founder Eric Carreel bought the connected device company back from Nokia two years ago, the company has charted a more clinical course. With $60 million in new funding, Withings plans to build out a remote monitoring program for its medical devices.
The company's new BPM Core model has the ability to measure blood pressure, record an EKG and listen to heart patterns with a digital stethoscope attachment.
The Microsoft co-founder and billionaire philanthropist's choices for the healthcare innovations that have the potential to change the world range from personalized cancer vaccines to voice assistants.
Apple's competitors in the wearables space including Fitbit, Withings and Garmin have cited their ability to do long term sleep monitoring as an advantage over Apple's products.
While the Study Watch was designed as investigational tool, it's likely the company will integrate features developed on the device onto its more consumer-oriented offerings.
Withings co-founder Eric Carreel bought the company back earlier this year after a somewhat disastrous tenure under Nokia and is now looking to forge a path forward in the crowded connected health space.
Two years after Nokia decided to acquire Withings for $192.3 million to grow a digital health business, it has sold the company back to Withings cofounder and chairman Éric Carreel.
The Verge, citing the memo, noted that Nokia’s chief strategy officer Kathrin Buvac told employees that “our digital health business has struggled to scale and meet its growth expectations.”
Nokia made clear in an announcement that all options are on the proverbial table for the digital health business, which is part of Nokia Technologies.
Nearly a year after its acquisition of Withings, Nokia highlighted product development news for digital health devices.
The $192.3 million deal underscores Nokia's interest in pushing into the digital health investment space following the launch of its $350 million Internet of Things fund in February.